Literature DB >> 1080630

Serum trypsin inhibitory capacity and pi phenotypes. II. Prevalence of alpha1-antitrypsin deficiency in an allergy population.

J Ihrig, H J Schwartz, D J Rynbrandt, J Kleinerman.   

Abstract

A series of 138 patients seen consecutively in an adult allergy clinic were studied to determine serum alpha1-antitrypsin (alpha1-AT) levels and protease inhibitor (Pi) phenotypes. These were compared with a control group of 700 healthy young adult blood donors. Both total serum trypsin inhibitory capacity (STIC) and alpha1-AT levels as determined by immunoelectrophoresis (IEP) were measured. Phenotypes were determined by antigen-antibody-crossed IEP. Alpha1-AT levels in the allergy group were not significantly different from control values. STIC in the allergy group was 1.34 +/- 0.28 mg. trypsin inhibited per ml. serum and in the controls, 1.32 +/- 0.28 mg. IEP values were 205 +/- vs. 200 +/- 36 mg. per dl. Similarly, no increase in Pi phenotypes known to be related to any disease state was observed. Since Pi phenotypes other than the most common MM are rare in Negro populations, phenotype data were corrected to include only Caucasian subjects. In the allergy group adjusted for racial composition we found 2.86% MZ, 5.72% MS; no SZ, SS or ZZ was detected. A comparable control group contained 3.68% MZ, 6.23% MS, 0.71% SZ-SS, but no ZZ Pi phenotype.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1080630     DOI: 10.1093/ajcp/64.3.297

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  5 in total

1.  Reference distributions for the positive acute phase proteins, alpha1-acid glycoprotein (orosomucoid), alpha1-antitrypsin, and haptoglobin: a comparison of a large cohort to the world's literature.

Authors:  R F Ritchie; G E Palomaki; L M Neveux; O Navolotskaia
Journal:  J Clin Lab Anal       Date:  2000       Impact factor: 2.352

2.  Protease inhibitor profile of black Americans with and without chronic cardiopulmonary disease.

Authors:  R C Young; V E Headings; A L Henderson; S Bose; R L Hackney
Journal:  J Natl Med Assoc       Date:  1978-11       Impact factor: 1.798

3.  Is PiSS Alpha-1 Antitrypsin Deficiency Associated with Disease?

Authors:  Dawn McGee; Laura Schwarz; Rebecca McClure; Lauren Peterka; Farshid Rouhani; Mark Brantly; Charlie Strange
Journal:  Pulm Med       Date:  2010-06-28

4.  T lymphocyte subset profile and serum alpha-1-antitrypsin in pathogenesis of chronic obstructive pulmonary disease.

Authors:  J Gupta; D Chattopadhaya; D P Bhadoria; M A Qadar Pasha; V K Gupta; M Kumar; R Dabur; V Yadav; G L Sharma
Journal:  Clin Exp Immunol       Date:  2007-06-12       Impact factor: 4.330

5.  The α(1)AT and TIMP-1 Gene Polymorphism in the Development of Asthma.

Authors:  Manish Kumar; D P Bhadoria; Koushik Dutta; Mitesh Kumar F; Bharat Singh; Seema Singh; Anil K Chhillar; D Behera; G L Sharma
Journal:  Comp Funct Genomics       Date:  2012-11-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.